Table 1. Criteria for the four-tiered CCC-CNS levels of evidence system.
| analytical performance | A Robust confirmation of sufficiently high analytical performance by one or more adequately designed and published round robin/ring trials |
| B Sufficient evidence for high analytical performance from adequately designed published investigations | |
| C Promising analytical performance from published investigations | |
| D Unclear analytical performance based on published single laboratory experience, inconsistent results between different studies, expert opinion | |
| clinical performance (prognostic/predictive) | A Robust confirmation of sufficiently high clinical performance by one or more adequately designed and published prospective studies |
| B Sufficient evidence for high clinical performance from adequately designed published investigations | |
| C Promising clinical performance from published investigations | |
| D Unclear clinical performance based on published single center experience, inconsistent results between different studies, expert opinion | |
| clinical utility | Both ≥ B = sufficient evidence for routine clinical use At least one < B = insufficient evidence for routine clinical use |